216 related articles for article (PubMed ID: 12817775)
1. Placebo controls in clinical trials of new therapies for osteoporosis.
Levine RJ
J Bone Miner Res; 2003 Jun; 18(6):1154-9. PubMed ID: 12817775
[No Abstract] [Full Text] [Related]
2. Osteoporosis panel summary.
Capron A; Donaldson S; Raisz LG; Swift S
J Bone Miner Res; 2003 Jun; 18(6):1160-2. PubMed ID: 12817776
[No Abstract] [Full Text] [Related]
3. Study design in osteoporosis: a European perspective.
Kanis JA; Alexandre JM; Bone HG; Abadie E; Brasseur D; Chassany O; Durrleman S; Lekkerkerker JF; Caulin F
J Bone Miner Res; 2003 Jun; 18(6):1133-8. PubMed ID: 12817770
[TBL] [Abstract][Full Text] [Related]
4. Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspective.
Rosenblatt M
J Bone Miner Res; 2003 Jun; 18(6):1142-5. PubMed ID: 12817772
[TBL] [Abstract][Full Text] [Related]
5. Study designs in osteoporosis.
Temple RJ
J Bone Miner Res; 2003 Jun; 18(6):1129-32. PubMed ID: 12817769
[No Abstract] [Full Text] [Related]
6. Is the use of placebo controls ethically permissible in clinical trials of agents intended to reduce fractures in osteoporosis?
Brody BA; Dickey N; Ellenberg SS; Heaney RP; Levine RJ; O'Brien RL; Purtilo RB; Weijer C
J Bone Miner Res; 2003 Jun; 18(6):1105-9. PubMed ID: 12817764
[TBL] [Abstract][Full Text] [Related]
7. The ethics of placebo-controlled trials.
Weijer C
J Bone Miner Res; 2003 Jun; 18(6):1150-3. PubMed ID: 12817774
[No Abstract] [Full Text] [Related]
8. A clinical perspective on placebo research: looking back, looking forward.
Dworkin RW
Am J Bioeth; 2009 Sep; 9(9):54-5. PubMed ID: 19998196
[No Abstract] [Full Text] [Related]
9. Ethics and science of placebo-controlled trials.
Healy D
J Psychopharmacol; 2008 Aug; 22(6):598-9. PubMed ID: 18308799
[No Abstract] [Full Text] [Related]
10. Research, medicine, and "placebos".
Moerman DE
Am J Bioeth; 2009 Sep; 9(9):64-5. PubMed ID: 19998201
[No Abstract] [Full Text] [Related]
11. The ethics of placebo-controlled trials.
Weijer C; Glass KC
N Engl J Med; 2002 Jan; 346(5):382-3. PubMed ID: 11821525
[No Abstract] [Full Text] [Related]
12. Placebo usage in clinical trials of lifesaving drugs.
Miller BL
Prog Clin Biol Res; 1980; 38():263-74. PubMed ID: 7384132
[No Abstract] [Full Text] [Related]
13. APS position statement on the use of placebos in pain management.
Sullivan M; Terman GW; Peck B; Correll DJ; Rich B; Clark WC; Latta K; Lebovits A; Gebhart G;
J Pain; 2005 Apr; 6(4):215-7. PubMed ID: 15820908
[TBL] [Abstract][Full Text] [Related]
14. Conflating scientific with clinical considerations.
van der Graaf R; van Delden JJ
Am J Bioeth; 2009 Sep; 9(9):58-9. PubMed ID: 19998198
[No Abstract] [Full Text] [Related]
15. Strengthening Howick's argument against the alleged superiority of placebo-controlled trials.
Rennie S; Stürmer T
Am J Bioeth; 2009 Sep; 9(9):62-4. PubMed ID: 19998200
[No Abstract] [Full Text] [Related]
16. A signature trial?
Siva N
Nat Clin Pract Urol; 2008 Nov; 5(11):579. PubMed ID: 18985048
[No Abstract] [Full Text] [Related]
17. Ethical issues in the difference between placebo-controlled and active-controlled trials.
Petrini C
Am J Bioeth; 2009 Sep; 9(9):56-8. PubMed ID: 19998197
[No Abstract] [Full Text] [Related]
18. Ethical issues in the design of osteoporosis clinical trials: the state of the question.
Heaney RP
J Bone Miner Res; 2003 Jun; 18(6):1117-20. PubMed ID: 12817766
[No Abstract] [Full Text] [Related]
19. Who's in control of the choice of control?
Anderson JA
Am J Bioeth; 2009 Sep; 9(9):60-2. PubMed ID: 19998199
[No Abstract] [Full Text] [Related]
20. More on the use of placebo controls.
IRB; 2001; 23(6):11. PubMed ID: 12737177
[No Abstract] [Full Text] [Related]
[Next] [New Search]
